trial · primary record
Cenegermin
Non-Arteritic Anterior Ischemic Optic Neuropathy
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 272 |
| Primary completion | 2027-09 |
| Primary endpoint | Achievement of ≥ 15 letter increase in Best Corrected Visual Acuity (BCVA), assessed in each individual participant, measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart |
| Registry ID | NCT07453888 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:20.384Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07453888
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.